These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6968063)

  • 1. [Immunological status and the results of levamisole treatment of patients with lymphocytic leukemia].
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Pol Tyg Lek; 1980 Apr; 35(17):617-21. PubMed ID: 6968063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular and humoral indicators of the immunomodulating effect of levamisole in patients with lymphocytic leukemia].
    Tretiak NN; Koval' AI; Minchenko ZhN; Sverstiuk AE
    Vrach Delo; 1985 Dec; (12):58-61. PubMed ID: 3879409
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of lymphocytic leukemia (morphological and immunological characteristics)].
    Chuvirov GN; Markova TP; Lebedev VN
    Ter Arkh; 1985; 57(7):64-6. PubMed ID: 3876615
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levamisole correction of immunologic disorders in patients with lymphocytic leukemia].
    Kozak VP
    Vrach Delo; 1985 May; (5):74-7. PubMed ID: 3874479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lymphocyte populations and serum immunoglobulins in patients with chronic lymphoid leukemia].
    Boretskiĭ VA
    Vrach Delo; 1982 Dec; (12):64-7. PubMed ID: 6984564
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of levamisole in infections and autoimmune hemolytic anemia in patients with chronic lymphoid leukemia and acute lymphoblastic anemia].
    Grigor'eva MA; Samoĭlova RS; Ermakova GL; Miterev GIu; Abakumov EM
    Gematol Transfuziol; 1983 Jun; 28(6):29-32. PubMed ID: 6603997
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological rebound following cessation of chemotherapy in 15 acute lymphoid leukemia patients in complete remission.
    De Rossi G; Tribalto M; Monarca B; Bolle C; Pasqualetti D; Mandelli F
    Biomedicine; 1978 Feb; 29(1):11-3. PubMed ID: 276383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction of the sensitivity of chronic lympholeukemia patients to levamisole].
    Martynova VA; Sevast'ianova MG; Ermakova GL
    Gematol Transfuziol; 1985 Sep; 30(9):7-10. PubMed ID: 3876965
    [No Abstract]   [Full Text] [Related]  

  • 9. [Method for the characterization of peripheral lymphocytes in humans and their significance].
    Magrì D; Spadacenta F; Tritto MC
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):102-7. PubMed ID: 6969080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the immune status of children with acute lymphocytic leukaemia. II. In remission with and without cytostatic treatment.
    Hitzig WH; Plüss HJ; Joller P; Pilgrim U; Tacier-Eugster H; Jakob M
    Clin Exp Immunol; 1976 Dec; 26(3):414-8. PubMed ID: 1087594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-immunologic evaluation of the effect of decaris (levamisole) in chronic lymphoid leukemia].
    Streneva TN; Shalaev VA; Krylova IV
    Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):20-3. PubMed ID: 6983689
    [No Abstract]   [Full Text] [Related]  

  • 12. Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood.
    Pullen DJ; Falletta JM; Crist WM; Vogler LB; Dowell B; Humphrey GB; Blackstock R; Eys JV; Cooper MD; Metzgar RS; Meydrech EF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4802-9. PubMed ID: 6975163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of levamisole on the peripheral lymphocyte population (T and B lymphocytes) in 2 cases of chronic lymphocytic leukemia].
    Kaloustian E; Harousseau JL; Krulik M; Mougeot-Martin M; Brault JL; Debray J
    Nouv Presse Med; 1977 Dec; 6(45):4208-9. PubMed ID: 305566
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface markers in human lymphoid leukaemias.
    Nadkarni JJ; Nadkarni JS; Advani SH
    Indian J Cancer; 1978 Dec; 15(4):43-7. PubMed ID: 317270
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of colony-stimulating activity (CSA) by T-chronic lymphocytic leukemia cells.
    Douer D; Ben-Bassat I; Shaked N; Ramot B
    Isr J Med Sci; 1985 Aug; 21(8):656-61. PubMed ID: 3876320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical stage and immunological findings in chronic lymphocytic leukemia.
    Baldini L; Mozzana R; Cesana B; Cortellezzi A; Neri A; Radaelli F
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):50-6. PubMed ID: 6433940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levamisole in chronic lymphocytic leukaemia: a prospective study of 15 patients.
    Aymard JP; Janot C; Thibaut G; Bertrand F; Legras B; Lederlin P; Streiff F
    Acta Haematol; 1984; 71(5):316-21. PubMed ID: 6429997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular and humoral immunity in children with lymphoblastic leukemia].
    Jagielski P; Litwin J; Rokicka-Milewska R; Derulska D; Madaliński K
    Pediatr Pol; 1981 Sep; 56(9):993-1001. PubMed ID: 6976553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-immunological comparisons during levamisole treatment of rheumatoid arthritis - abuse of correlations between cellular immunity indicators and treatment results].
    Chumakova MM; Bunchuk NV
    Ter Arkh; 1981; 53(6):83-7. PubMed ID: 6974413
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients].
    Borisova AM; Novikova TA; Glazko AV
    Ter Arkh; 1984; 56(10):29-31. PubMed ID: 6335306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.